Biospecimen Collection (NCT06008730)

Name: Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730)
Uploaded: 2026-10-31T22:35:38.222Z
Duration: 1 min 3 s
Description: Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06008730.

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer: a one-minute explainerNCT060087301 min

Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adults with non-small cell lung cancer completely removed after preoperative systemic therapy, with cancer found in mediastinal lymph nodes. Stage IV disease and targetable EGFR or ALK alterations are excluded.

The idea: proton radiation aims to kill remaining cancer cells while limiting exposure to healthy tissue. Researchers assess side effects and cancer control after surgery. Blood samples also examine effects on the immune system. Radiation doses are not published.

This phase 2 study plans 10 patients. Emory’s William Stokes leads it in Atlanta, the single recruiting US site.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.